Related Experiment Video
Updated: May 24, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Rituximab: current status as therapy for malignant and benign hematologic disorders
Nihal E Abdulla1, Mary J Ninan, Avi B Markowitz
1Division of Hematology/Oncology, University of Texas Medical Branch, Galveston, TX 77555-0565, USA.
Summary
Rituximab, a CD20-targeting antibody, is effective for various cancers and autoimmune disorders. Its clinical development shows minimal toxicity and broad application in hematology and oncology.
Area of Science:
- Oncology and Hematology
- Immunotherapy
Background:
- Rituximab is a chimeric monoclonal antibody targeting CD20.
- It was the first monoclonal antibody approved for cancer treatment.
- Its efficacy and safety have been explored in diverse clinical conditions.
Purpose of the Study:
- To discuss the clinical development of rituximab.
- To review efficacy data from clinical trials.
- To outline its current status in hematology and oncology practice.
Main Methods:
- Review of clinical trial data.
- Analysis of rituximab's efficacy in various hematologic conditions.
- Evaluation of its use as monotherapy and in combination with chemotherapy.
Main Results:
- Rituximab demonstrates efficacy in CD20-positive lymphomas and chronic lymphocytic leukemia.
- It is effective in non-malignant hematologic disorders like autoimmune hemolytic anemia and immune thrombocytopenic purpura.
- Proven effective in both untreated and relapsed/refractory settings, as induction and maintenance therapy.
Conclusions:
- Rituximab is a valuable therapeutic agent in hematology and oncology.
- Its clinical development highlights its effectiveness with minimal toxicity.
- It remains a significant treatment option for CD20-positive malignancies and certain autoimmune conditions.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...